Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union - an inter-laboratory study

Thumbnail
Date
2004-08
ICR Author
Coleman, Dereck
Author
Wells, CA
Sloane, JP
Coleman, D
Munt, C
Amendoeira, I
Apostolikas, N
Bellocq, JP
Bianchi, S
Boecker, W
Bussolati, G
Connolly, CE
Dervan, P
Drijkoningen, M
Ellis, IO
Elston, CW
Eusebi, V
Faverly, D
Heikkila, P
Holland, R
Jacquemier, J
Lacerda, M
Martinez-Penuela, J
De Miguel, C
Peterse, JL
Rank, F
Reiner, A
Saksela, E
Sigal-Zafrani, B
Sylvan, M
Borisch, B
Cserni, G
Decker, T
Kerner, H
Kulka, J
Regitnig, P
Sapino, A
Tanous, AM
Thorstenson, S
Zozaya, E
Screen, EWGB
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
To assess the variability of oestrogen receptor (ER) testing using immunocytochemistry, centrally stained and unstained slides from breast cancers were circulated to the members of the European Working Group for Breast Screening Pathology, who were asked to report on both slides. The results showed that there was almost complete concordance among readers (kappa=0.95) in ER-negative tumours on the stained slide and excellent concordance among readers (kappa=0.82) on the slides stained in each individual laboratory. Tumours showing strong positivity were reasonably well assessed (kappa=0.57 and 0.4, respectively), but there was less concordance in tumours with moderate and low levels of ER, especially when these were heterogeneous in their staining. Because of the variation, the Working Group recommends that laboratories performing these stains should take part in a external quality assurance scheme for immunocytochemistry, should include a tumour with low ER levels as a weak positive control and should audit the percentage positive tumours in their laboratory against the accepted norms annually. The Quick score method of receptor assessment may also have too many categories for good concordance, and grouping of these into fewer categories may remove some of the variation among laboratories.
URI
https://repository.icr.ac.uk/handle/internal/2625
DOI
https://doi.org/10.1007/s00428-004-1063-8
Collections
  • Other ICR Research
Language
eng
License start date
2004-08
Citation
VIRCHOWS ARCHIV, 2004, 445 pp. 119 - 128
Publisher
SPRINGER

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.